Skip to content

Clinical trials

Terminated Pancreatic Neoplasms trials in Belgium

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pancreatic Neoplasms Status: Terminated Country / region: Belgium Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20072
20091
20121
20131
20141
20162
20171
20182
20211
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated14

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Incyte Corporation2
Novartis Pharmaceuticals2
Pfizer2
ADC Therapeutics S.A.1
Day One Biopharmaceuticals, Inc.1
Gilead Sciences1
NantBioScience, Inc.1
Pharmexa A/S1
SOTIO Biotech a.s.1
Sanofi1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pancreatic Neoplasms14
Carcinoma, Non-Small-Cell Lung4
Colorectal Neoplasms3
Melanoma3
Adenocarcinoma2
Carcinoma, Renal Cell2
Ovarian Neoplasms2
Triple Negative Breast Neoplasms2
Urinary Bladder Neoplasms2
Astrocytoma1

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.